Erratum: RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer (Gynecologic Oncology (2012) 124 (589-597))

Prakash Vishnu; Gerardo Colon-Otero; Gregory T. Kennedy; Laura A. Marlow; William P. Kennedy; Kevin J. Wu; Joseph T. Santoso; John A. Copland

doi:10.1016/j.ygyno.2012.09.014

Erratum: RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer (Gynecologic Oncology (2012) 124 (589-597))

Prakash Vishnu, Gerardo Colon-Otero, Gregory T. Kennedy, Laura A. Marlow, William P. Kennedy, Kevin J. Wu, Joseph T. Santoso, John A. Copland

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	680
Number of pages	1
Journal	Gynecologic oncology
Volume	127
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2012.09.014
State	Published - Dec 2012

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2012.09.014

Cite this

@article{1b10ee8e812b40919a6e801284d54a85,

title = "Erratum: RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer (Gynecologic Oncology (2012) 124 (589-597))",

author = "Prakash Vishnu and Gerardo Colon-Otero and Kennedy, {Gregory T.} and Marlow, {Laura A.} and Kennedy, {William P.} and Wu, {Kevin J.} and Santoso, {Joseph T.} and Copland, {John A.}",

note = "Funding Information: We thank the Mayo Clinic Cancer Center for the use of the Genotyping Core, which provided short tandem repeat analysis services. Mayo Clinic Cancer Center is supported in part by an NCI Cancer Center Support Grant 5P30 CA15083-37. This work was funded in part from Mayo Clinic Research Committee (GC-O), NIH/NCI grant R01CA136665 and Mayo Clinic base budget (JAC).",

year = "2012",

month = dec,

doi = "10.1016/j.ygyno.2012.09.014",

language = "English (US)",

volume = "127",

pages = "680",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Erratum

T2 - RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer (Gynecologic Oncology (2012) 124 (589-597))

AU - Vishnu, Prakash

AU - Colon-Otero, Gerardo

AU - Kennedy, Gregory T.

AU - Marlow, Laura A.

AU - Kennedy, William P.

AU - Wu, Kevin J.

AU - Santoso, Joseph T.

AU - Copland, John A.

N1 - Funding Information: We thank the Mayo Clinic Cancer Center for the use of the Genotyping Core, which provided short tandem repeat analysis services. Mayo Clinic Cancer Center is supported in part by an NCI Cancer Center Support Grant 5P30 CA15083-37. This work was funded in part from Mayo Clinic Research Committee (GC-O), NIH/NCI grant R01CA136665 and Mayo Clinic base budget (JAC).

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84868556446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868556446&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2012.09.014

DO - 10.1016/j.ygyno.2012.09.014

M3 - Comment/debate

AN - SCOPUS:84868556446

SN - 0090-8258

VL - 127

SP - 680

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 3

ER -

Erratum: RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer (Gynecologic Oncology (2012) 124 (589-597))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this